SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-08-017282
Filing Date
2008-03-25
Accepted
2008-03-25 16:09:41
Documents
10

Document Format Files

Seq Description Document Type Size
1 v107961_sc13d.htm SC 13D 104590
2 v107961_ex99-2.htm EX-99.2 778
3 GRAPHIC v107961_ex99-2x1x1.jpg GRAPHIC 99439
4 GRAPHIC v107961_ex99-2x2x1.jpg GRAPHIC 139555
5 GRAPHIC v107961_ex99-2x3x1.jpg GRAPHIC 54974
6 GRAPHIC v107961_ex99-2x4x1.jpg GRAPHIC 30109
7 v107961_ex99-3.htm EX-99.3 628
8 GRAPHIC v107961_ex99-3x1x1.jpg GRAPHIC 91662
9 GRAPHIC v107961_ex99-3x2x1.jpg GRAPHIC 118446
10 GRAPHIC v107961_ex99-3x3x1.jpg GRAPHIC 23855
  Complete submission text file 0001144204-08-017282.txt   877908
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-37761 | Film No.: 08709546
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address SALISBURY HOUSE, STATION ROAD, CAMBRIDGE X0 CB1 2L
Business Address SALISBURY HOUSE, STATION ROAD, CAMBRIDGE X0 CB1 2L 44 207 932 2100
Lorantis Holdings LTD (Filed by) CIK: 0001430324 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D